Tyrosine Kinase Activity and Transformation Potency of bcr-abl Oncogene Products-Reference-Cited by-同舟云学术

Tyrosine Kinase Activity and Transformation Potency of bcr-abl Oncogene Products

Published:1990-03-02 Issue:4946 Volume:247 Page:1079-1082
ISSN:0036-8075
Container-title:Science
language:en
Short-container-title:Science

Author:

Lugo Tracy G.¹,Pendergast Ann-Marie¹,Muller Alexander J.¹,Witte Owen N.¹

Affiliation:

1. Department of Microbiology and Molecular Biology Institute and the Howard Hughes Medical Institute, University of California, Los Angeles, CA 90024.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference25 articles.

1. The Chronic Myelogenous Leukemia-Specific P210 Protein Is the Product of the bcr / abl Hybrid Gene

2. BRUGGE, J.S., ANALYSIS OF THE CATALYTIC DOMAIN OF PHOSPHOTRANSFERASE ACTIVITY OF 2 AVIAN-SARCOMA VIRUS-TRANSFORMING PROTEINS, JOURNAL OF BIOLOGICAL CHEMISTRY 259: 4550 (1984).

3. CHEN, S.J., PHILADELPHIA-POSITIVE ACUTE-LEUKEMIA - LINEAGE PROMISCUITY AND INCONSISTENTLY REARRANGED BREAKPOINT CLUSTER REGION, LEUKEMIA 2: 261 (1988).

4. Unique Forms of the abl Tyrosine Kinase Distinguish Ph 1 -Positive CML from Ph 1 -Positive ALL

5. Expression of a Distinctive BCR-ABL Oncogene in Ph 1 -Positive Acute Lymphocytic Leukemia (ALL)

Cited by 1136 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BCR::ABL1 Proteolysis-targeting chimeras (PROTACs): The new frontier in the treatment of Ph+ leukemias?;Leukemia;2024-08-04

2. REXO5 promotes genomic integrity through regulating R-loop using its exonuclease activity;Leukemia;2024-07-30

3. Vitamin C Supplementation in the Treatment of Autoimmune and Onco-Hematological Diseases: From Prophylaxis to Adjuvant Therapy;International Journal of Molecular Sciences;2024-07-02

4. Cell-penetrating peptide and cationic liposomes mediated siRNA delivery to arrest growth of chronic myeloid leukemia cells in vitro;Biochimie;2024-06

5. Design, in silico Evaluation, and Determination of Antitumor Activity of Potential Inhibitors Against Protein Kinases: Application to BCR-ABL Tyrosine Kinase;Biochemistry (Moscow);2024-06